Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
29.68
+0.34 (1.16%)
Nov 19, 2024, 4:00 PM EST - Market closed

Dyne Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
141
Market Cap
3.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Surgery Partners 2.99B
Amedisys 2.32B
LivaNova 1.24B
LifeStance Health Group 1.21B
ACADIA Pharmaceuticals 929.24M
HUTCHMED (China) 610.81M
Amicus Therapeutics 493.67M
Veracyte 425.33M
Revenue Rankings